Literature DB >> 7701811

Detection and characterization of Lewis antigens in plasma of Lewis-negative individuals. Evidence of chain extension as a result of reduced fucosyltransferase competition.

S M Henry1, R Oriol, B E Samuelsson.   

Abstract

Nonacid plasma glycolipids from Lewis-negative individuals of nonsecretor, partial-secretor and secretor phenotypes were prepared and separated by thin-layer chromatography and immunostained with radiolabelled Lewis antibodies. Lewis-positive plasma and intestinal epithelial cell glycolipids from Caucasians representing the four recognized Lewis and secretor combined phenotypes were used as controls. By presenting these purified total glycolipids in a cell-free environment to Lewis antibodies we were able to demonstrate the presence of small amounts of Lewis antigens in Lewis-negative individuals. It is shown that lactotetraosylceramide and extended precursor glycolipids are present in all Le(a-b-) nonsecretors. Le(a) was detected in 1 of the 3 Le(a-b-) nonsecretor plasmas and in the intestinal sample of the same phenotype. Lactotetraosylceramide was absent but H type 1 and Le(b) were both present in all group O Le(a-b-) secretors, and extended H type 1 reactive structures were also found in the partial secretor. These results clearly demonstrate that although the Lewis-negative phenotype exists at the serological level, this phenotype is not an 'all-or-nothing' phenomenon at the chemical level. We also show that in the presence of reduced fucosyltransferase activity, increased elongation of the precursor chain occurs, which allows us to postulate that fucosylation of the precursor prevents or at least markedly reduces chain elongation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7701811     DOI: 10.1111/j.1423-0410.1994.tb01279.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  8 in total

1.  Structural and immunochemical identification of Leb glycolipids in the plasma of a group O Le(a-b-) secretor.

Authors:  S M Henry; P A Jovall; S Ghardashkhani; M L Gustavsson; B E Samuelsson
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

2.  Relationship between ABO blood groups and carcinoma of esophagus and cardia in Chaoshan inhabitants of China.

Authors:  M Su; S M Lu; D P Tian; H Zhao; X Y Li; D R Li; Z C Zheng
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

3.  Comparison of oligosaccharides derived from salivary mucin of Japanese secretor and non-secretor individuals of blood group type-A.

Authors:  T Ohmori; H Toyoda; T Toida; T Imanari; H Sato
Journal:  Glycoconj J       Date:  2001-08       Impact factor: 2.916

Review 4.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  Structural and immunochemical identification of Le(a), Le(b), H type 1, and related glycolipids in small intestinal mucosa of a group O Le(a-b-) nonsecretor.

Authors:  S Henry; P A Jovall; S Ghardashkhani; A Elmgren; T Martinsson; G Larson; B Samuelsson
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

Review 6.  Human milk oligosaccharides and Lewis blood group: individual high-throughput sample profiling to enhance conclusions from functional studies.

Authors:  Dennis Blank; Viktoria Dotz; Rudolf Geyer; Clemens Kunz
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

7.  SSEA3 and Sialyl Lewis a Glycan Expression Is Controlled by B3GALT5 LTR through Lamin A-NFYA and SIRT1-STAT3 Signaling in Human ES Cells.

Authors:  Bi-He Cai; Hsueh-Yi Lee; Chi-Kan Chou; Po-Han Wu; Hsiang-Chi Huang; Chia-Chun Chao; Hsiao-Yu Chung; Reiji Kannagi
Journal:  Cells       Date:  2020-01-10       Impact factor: 6.600

Review 8.  Histo-blood group glycans in the context of personalized medicine.

Authors:  Viktoria Dotz; Manfred Wuhrer
Journal:  Biochim Biophys Acta       Date:  2015-12-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.